vTv Therapeutics (VTVT) Interest Coverage Ratio Growth (1y) (2015 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 15.31% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -76.51% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -303.06% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 18.06% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -26.72% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,150.63% |
| 10 | vTv Therapeutics | 413.85 Mn | 413.85 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 36.39% |
| Sep 30, 2023 | -88.72% |
| Dec 31, 2022 | 42.90% |
| Sep 30, 2022 | -166.17% |
| Dec 31, 2021 | -6,878.72% |
| Sep 30, 2021 | -2,116.96% |
| Dec 31, 2020 | 221.00% |
| Sep 30, 2020 | 10.26% |
| Jun 30, 2020 | -103.12% |
| Mar 31, 2020 | -477.66% |
| Dec 31, 2019 | -4,678.15% |
| Sep 30, 2019 | -645.31% |
| Jun 30, 2019 | 8.43% |
| Mar 31, 2019 | 35.90% |
| Dec 31, 2018 | 96.85% |
| Sep 30, 2018 | 86.75% |
| Jun 30, 2018 | 32.85% |
| Mar 31, 2018 | 56.58% |
| Dec 31, 2017 | 55.52% |
| Jun 30, 2017 | 99.90% |
| Mar 31, 2017 | 99.64% |
| Dec 31, 2016 | -573.80% |
| Jun 30, 2016 | -148,349.74% |
| Mar 31, 2016 | -37,437.60% |
| Dec 31, 2015 | 462.85% |
| Sep 30, 2015 | 11.36% |
| Jun 30, 2015 | 98.08% |